GW Pharma Q3 Beats Expectations with Revenue of $137 Million

New Cannabis Ventures
By NCV NewswireNov 3, 2020, 8:06 am244 pts
GW Pharmaceuticals plc Reports Third Quarter 2020 Financial Results and Operational Progress Total revenue increased 51 percent to $137.1 million Epidiolex for seizures associated with TSC launched in the U.S. Nabiximols Phase 3 program in MS spasticity now recruiting Conference call today at 8:30 a.m. EST…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Following Medicaid Cuts and Deadly Federal Raids, Medical Cannabis Patients Heighten Call for Renewed Protections 79

Massachusetts’s Social Equity Cannabis Program Is Back On Track After A Year On Pause 77

Congressional Committee Moves To Block Marijuana Rescheduling 77

Delaware Governor Weighs ‘Competing Priorities’ As Marijuana Zoning Bill Sits On His Desk 76

Cannabis Therapeutics conference set for Sept 14-16 in VA 74

Aurora Cannabis earns EU-GMP certification for fourth marijuana facility 73

Aurora Cannabis receives EU-GMP certification for its Ontario distribution centre 73

Worker Killed, Hundreds Arrested During ICE Raids on California Cannabis Farms 72

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.